DE2461050C2 - 6,7-Dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydrochinolin-1-carbonsäureäthylester und Verfahren zu dessen Herstellung - Google Patents

6,7-Dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydrochinolin-1-carbonsäureäthylester und Verfahren zu dessen Herstellung

Info

Publication number
DE2461050C2
DE2461050C2 DE2461050A DE2461050A DE2461050C2 DE 2461050 C2 DE2461050 C2 DE 2461050C2 DE 2461050 A DE2461050 A DE 2461050A DE 2461050 A DE2461050 A DE 2461050A DE 2461050 C2 DE2461050 C2 DE 2461050C2
Authority
DE
Germany
Prior art keywords
acid
dimethoxy
compound
ester
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2461050A
Other languages
German (de)
English (en)
Other versions
DE2461050A1 (de
Inventor
Charles Armon Waterford Conn. Harbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE2461050A1 publication Critical patent/DE2461050A1/de
Application granted granted Critical
Publication of DE2461050C2 publication Critical patent/DE2461050C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
DE2461050A 1973-12-26 1974-12-20 6,7-Dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydrochinolin-1-carbonsäureäthylester und Verfahren zu dessen Herstellung Expired DE2461050C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42844173A 1973-12-26 1973-12-26

Publications (2)

Publication Number Publication Date
DE2461050A1 DE2461050A1 (de) 1975-07-17
DE2461050C2 true DE2461050C2 (de) 1983-12-29

Family

ID=23698907

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2461050A Expired DE2461050C2 (de) 1973-12-26 1974-12-20 6,7-Dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydrochinolin-1-carbonsäureäthylester und Verfahren zu dessen Herstellung

Country Status (21)

Country Link
JP (1) JPS582937B2 (fr)
AR (1) AR205807A1 (fr)
BE (1) BE823811A (fr)
CA (1) CA1035360A (fr)
DD (1) DD117454A5 (fr)
DE (1) DE2461050C2 (fr)
DK (1) DK138889B (fr)
ES (1) ES433305A1 (fr)
FI (1) FI368374A (fr)
FR (1) FR2255906B1 (fr)
GB (1) GB1454039A (fr)
HU (1) HU169380B (fr)
IE (1) IE40329B1 (fr)
IL (1) IL46232A0 (fr)
LU (1) LU71558A1 (fr)
NL (1) NL7416666A (fr)
NO (1) NO744670L (fr)
RO (1) RO64270A (fr)
SE (1) SE421417B (fr)
SU (1) SU538663A3 (fr)
ZA (1) ZA748171B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978064A (en) * 1975-11-04 1976-08-31 Pfizer Inc. 3-Aminomethylene-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoline carboxylic acid esters and intermediates leading thereto

Also Published As

Publication number Publication date
FR2255906B1 (fr) 1978-06-30
DD117454A5 (fr) 1976-01-12
ZA748171B (en) 1976-01-28
DK138889C (fr) 1979-04-30
HU169380B (fr) 1976-11-28
DK653874A (fr) 1975-08-25
CA1035360A (fr) 1978-07-25
SU538663A3 (ru) 1976-12-05
AR205807A1 (es) 1976-06-07
JPS582937B2 (ja) 1983-01-19
RO64270A (fr) 1979-05-15
NL7416666A (nl) 1975-06-30
GB1454039A (en) 1976-10-27
DE2461050A1 (de) 1975-07-17
IE40329B1 (en) 1979-05-09
JPS50105672A (fr) 1975-08-20
BE823811A (fr) 1975-06-24
SE7415497L (fr) 1975-06-27
LU71558A1 (fr) 1975-08-20
AU7658174A (en) 1976-06-24
FI368374A (fr) 1975-06-27
IE40329L (en) 1975-06-26
ES433305A1 (es) 1977-03-01
SE421417B (sv) 1981-12-21
IL46232A0 (en) 1975-03-13
FR2255906A1 (fr) 1975-07-25
DK138889B (da) 1978-11-13
NO744670L (fr) 1975-07-21

Similar Documents

Publication Publication Date Title
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
DD127966B3 (de) Verfahren zur herstellung von pyrrolidinderivaten
DD209622A5 (de) Verfahren zur herstellung von 1,4-dihydropyridinen
DE2851435A1 (de) Substituierte amid-derivate des l- und dl-phenylglycins, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel
DE3615293A1 (de) Verwendung von heteroarylethylaminen zur leistungsfoerderung bei tieren, heteroarylethylamine und verfahren zu ihrer herstellung
DE2237592C2 (de) 6-(o-Chlorphenyl)-8-chlor-4H-imidazo-[1,2-a] [1,4]-benzodiazepine und Verfahren zu ihrer Herstellung
DE1518452C3 (de) 4 substituierte 2 Benzhydryl 2 butanol Derivate und Verfahren zu ihrer Herstellung
EP0431371B1 (fr) 3-Aminopyrroles, procédé pour leur préparation et leur utilisation comme anticonvulsifs
DE3784835T2 (de) Chinoxalinon-derivate.
DE2659932C2 (de) Racemischer 3-Hydroxymethylen-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-chinolincarbonsäureäthylester
DE2461050C2 (de) 6,7-Dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydrochinolin-1-carbonsäureäthylester und Verfahren zu dessen Herstellung
DE2723051A1 (de) N-(acyl)-p-amino-n'-(monosubstit.)- benzamide sowie diese enthaltende arzneimittel
DE3850222T2 (de) 1,4-Disubstituierte-piperidinyl-Verbindungen.
DE1905353C3 (de) 2-Benzylimidazolinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen
DE3642497A1 (de) Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
DE2748466A1 (de) 4a-aryloctahydro-1h-2-pyrindine
DE2123318A1 (de) Aminoderivate von Pyrazolopyridincarbonsäuren, deren Estern und Salzen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2122259A1 (de) alpha-Aminoalkyl-4-hydroxy-3-carboalkoxyaminobenzylalkohole, ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneipräparate
DE2535599A1 (de) Substituierte zimtsaeureamide, verfahren zu ihrer herstellung und diese verbindungen enthaltende zubereitungen
DE2609574C3 (de) 1 -^-Fluor-S-trifluormethylthiophenyD-piperazin, dessen Salze, Verfahren zu dessen Herstellung und Arzneimittel
DE2300050A1 (de) 6,7-substituierte-chinazolinone
DD246299A5 (de) Verfahren zur herstellung n-substituierter anziridin-2-carbonsaeurederivaten
DE3423003A1 (de) Benzo(c)(1,8)naphthyridine, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
CH615153A5 (fr)
DE3129719C2 (de) Pharmazeutisches Mittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8125 Change of the main classification
8181 Inventor (new situation)

Free format text: HARBERT, CHARLES ARMON, WATERFORD, CONN., US

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee